243 – Why Kitting A Finished Medical Device with a Drug Create So Much Work

Chat with Subhi: https://calendly.com/letscombinate/let-s-combinate-intro-session

Finished medical devices can create a lot of surprises when they are added to combination product kits.

A needle, vial adapter, filter, or transfer device may already be sterile, cleared, qualified, and sold at massive scale.

But already on the market does not automatically mean ready for your combination product.

In this episode, I talk through the challenges of selecting finished medical devices for combination product kits and the three lifecycle moments that usually determine whether qualification goes smoothly or turns into a late-stage problem.

We cover:

* Why “already approved” does not mean combination-product ready

* Why you inherit the supplier’s design, QMS, packaging, validation, change control, and outsourcing decisions

* What to think about before supplier selection

* How to set expectations during supplier selection

* Why structured qualification matters

* How PPAP concepts like process flow, PFMEA, control plans, inspections, sampling, and validation evidence can help

The main point: A commercially available device may be qualified for someone else’s intended use. Your job is to determine whether it is qualified for yours.

Chapters:

00:00 Device Selection Stakes

02:05 Common Supplier Myths

03:54 Inheriting the Device QMS

04:53 Three Crucial Moments

05:51 Before Selection: Intended Use

07:21 Packaging, Markets, and Risk Flags

08:55 During Selection: Set Expectations

10:33 Qualification: Use a Structured PPAP Approach

14:12 Wrap Up and Next Steps

Subhi Saadeh is the Founder and Principal at Let’s Combinate, where he helps teams develop and control drug-device combination products by aligning quality systems, development, supplier quality, and regulatory expectations across drug and device domains. He is a consultant, auditor, trainer, and speaker with experience across companies including Pfizer, Gilead, and Baxter, supporting the development and launch of combination products across vaccines, biologics, and generics.

Let’s Combinate helps teams develop and control drug-device combination products by aligning quality systems, development, supplier quality, and regulatory expectations across drug and device domains.

#CombinationProducts #MedicalDevices #PharmaQuality #SupplierQuality #DrugDeviceCombinationProducts #PPAP #QualitySystems